Kathleen Jane Cullion, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tetrodotoxin | 3 | 2023 | 244 | 1.200 |
Why?
|
| Nerve Block | 3 | 2020 | 715 | 1.200 |
Why?
|
| Ultrasonics | 2 | 2020 | 209 | 1.180 |
Why?
|
| Anesthesia, Local | 2 | 2020 | 276 | 1.090 |
Why?
|
| Bupivacaine | 2 | 2020 | 432 | 1.060 |
Why?
|
| Anesthetics, Local | 3 | 2020 | 1015 | 0.890 |
Why?
|
| Nanoshells | 1 | 2023 | 11 | 0.870 |
Why?
|
| Hyperthermia, Induced | 1 | 2023 | 415 | 0.660 |
Why?
|
| Delayed-Action Preparations | 2 | 2023 | 967 | 0.550 |
Why?
|
| Microbubbles | 1 | 2018 | 136 | 0.540 |
Why?
|
| Drug Delivery Systems | 4 | 2023 | 2207 | 0.460 |
Why?
|
| Liposomes | 1 | 2018 | 788 | 0.440 |
Why?
|
| Nanoparticles | 1 | 2021 | 1964 | 0.330 |
Why?
|
| Receptor, Notch1 | 2 | 2011 | 517 | 0.330 |
Why?
|
| Cyclic S-Oxides | 1 | 2009 | 23 | 0.320 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2011 | 385 | 0.310 |
Why?
|
| Thiadiazoles | 1 | 2009 | 64 | 0.310 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 434 | 0.270 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2011 | 618 | 0.250 |
Why?
|
| Ultrasonography | 1 | 2018 | 5993 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 8102 | 0.220 |
Why?
|
| Aptamers, Nucleotide | 1 | 2023 | 163 | 0.190 |
Why?
|
| Tympanic Membrane | 1 | 2023 | 233 | 0.180 |
Why?
|
| Otitis Media | 1 | 2023 | 287 | 0.170 |
Why?
|
| Phototherapy | 1 | 2023 | 370 | 0.170 |
Why?
|
| Gold | 1 | 2023 | 482 | 0.160 |
Why?
|
| Phosphatidylethanolamines | 1 | 2019 | 128 | 0.160 |
Why?
|
| Micelles | 1 | 2019 | 188 | 0.160 |
Why?
|
| Drug Compounding | 1 | 2019 | 235 | 0.150 |
Why?
|
| Tissue Distribution | 2 | 2019 | 2266 | 0.150 |
Why?
|
| Self Administration | 1 | 2018 | 385 | 0.140 |
Why?
|
| Injections | 1 | 2019 | 840 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2009 | 4913 | 0.130 |
Why?
|
| Animals | 9 | 2023 | 168764 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2019 | 700 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2021 | 2230 | 0.120 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 628 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 1140 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 1188 | 0.110 |
Why?
|
| Rats | 2 | 2020 | 23707 | 0.110 |
Why?
|
| Metalloproteins | 1 | 2011 | 98 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18293 | 0.090 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 1084 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2011 | 4520 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1701 | 0.060 |
Why?
|
| Sex Factors | 1 | 2019 | 10603 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2009 | 703 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20124 | 0.060 |
Why?
|
| Sodium Channel Blockers | 1 | 2023 | 170 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5881 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 81819 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 9601 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5020 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6113 | 0.050 |
Why?
|
| Histamine | 1 | 2023 | 497 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9550 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2056 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 765968 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2006 | 1263 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10429 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9514 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2081 | 0.030 |
Why?
|
| Male | 3 | 2019 | 363698 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 1770 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 12131 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2011 | 1866 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 1261 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 23601 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2060 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7478 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1352 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
| Female | 2 | 2019 | 396112 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2745 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2900 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6499 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 4165 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3715 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4137 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18973 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13400 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17594 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22332 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 17075 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11641 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 30198 | 0.000 |
Why?
|